
Digestive Cancers Europe/X
Aug 20, 2025, 18:34
Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights – Digestive Cancers Europe
Digestive Cancers Europe shared a post on X:
“Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights
PANOVA-3 showed Tumour Treating Fields with chemotherapy improved survival and pain-free outcomes. CASSANDRA found PAXG extended event-free survival over mFOLFIRINOX.
TEDOPAM demonstrated that a cancer vaccine plus chemotherapy significantly improved one-year survival with minimally added toxicity for advanced disease.
More posts featuring Digestive Cancers Europe.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 20, 2025, 18:26
Aug 20, 2025, 17:39
Aug 20, 2025, 17:21
Aug 20, 2025, 17:09
Aug 20, 2025, 16:55
Aug 20, 2025, 16:15